GX1 Trademark

Trademark Overview

On Monday, April 10, 2023, a trademark application was filed for GX1 with the United States Patent and Trademark Office. The USPTO has given the GX1 trademark a serial number of 97880431. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, February 5, 2024. This trademark is owned by Boston Scientific Neuromodulation Corporation. The GX1 trademark is filed in the Medical Instrument Products category with the following description:

medical radiofrequency generator and ablation device for pain management
gx1

General Information

Serial Number97880431
Word MarkGX1
Filing DateMonday, April 10, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, February 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkGX ONE
Goods and Servicesmedical radiofrequency generator and ablation device for pain management

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, May 3, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoston Scientific Neuromodulation Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressValencia, CA 91355

Trademark Events

Event DateEvent Description
Thursday, April 13, 2023NEW APPLICATION ENTERED
Wednesday, May 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 14, 2023ASSIGNED TO EXAMINER
Wednesday, June 21, 2023NON-FINAL ACTION WRITTEN
Wednesday, June 21, 2023NON-FINAL ACTION E-MAILED
Wednesday, June 21, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 19, 2023FINAL REFUSAL WRITTEN
Thursday, October 19, 2023FINAL REFUSAL E-MAILED
Thursday, October 19, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, February 5, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, February 5, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Related Keywords

pain management device ablation radiofrequency generator medical